BackBasilea Pharmaceutica AG Overview

Basilea Pharmaceutica AG Inventory

Basilea Pharmaceutica AG's inventory is $26M.

Get informed when a big investor buys or sells

+ Follow
Inventory
$26.04M
↑ 15.09% YoYΔ $3.41M vs prior year quarter

Peer trimmed avg / median

Loading

Basilea Pharmaceutica AG Inventory History

Loading

Basilea Pharmaceutica AG vs. peers: Inventory Comparison

Loading

Basilea Pharmaceutica AG Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Basilea Pharmaceutica AG (BSLN.SW) FAQ

As of the most recent data (June 2026), BSLN.SW shows a inventory of $26M. That compares with $23M in the prior-year period — up 15.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BSLN.SW's inventory is now $26M (was $23M) — a 15.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Basilea Pharmaceutica AG is outperforming or lagging.

Tracking BSLN.SW's inventory over time shows whether Basilea Pharmaceutica AG is scaling, shrinking, or reshaping that part of the business. The current reading is $26M That compares with $23M in the prior-year period — up 15.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this inventory page, Stockcircle has Basilea Pharmaceutica AG's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect inventory (currently $26M) with ownership activity and broader fundamentals.

Basilea Pharmaceutica AG's inventory is $26M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.